Mar 24, 2021 / 05:15PM GMT
Matthew Ian Mishan - KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research Analyst
Well, good afternoon, and welcome to the second day of the inaugural KeyBanc Life Sciences and MedTech Investor Forum. My name is Matt Mishan, I'm a senior MedTech analyst. I'm pleased to be joined by CFO, Brian Andrews, from CooperCompanies.
If you have any questions, there is a Q&A box on the bottom of the screen that goes directly to me. And I will do my best to get to the questions as they come through.
With that, I think we'll just get started with the questions. And Brian, thank you for joining us.
Brian G. Andrews - The Cooper Companies, Inc. - Executive VP, CFO & Treasurer
Matt, pleasure to be here. Thanks for having me.
Questions and Answers:
Matthew Ian Mishan - KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research AnalystI know you just reported, but could you give us an overview of how Cooper sees the recovery progressing in its core